Q: Please provide your view on the latest quarterly report and outlook.
Thanks
Thanks
5i Research Answer:
Loss of 52c missed estimates of -35c; revenue of $2.2M missed estimates of $3.3M. EBITDA of -$13.7M missed estimates by 27%. This is still very much a 'show me' story. PRN is targetting 70%+ growth this year. Procedure volume is growing, as is the qualified pipeline. Cash is $35M, but 12-month cash flow was -$34M. Sales are predicted to double next year and the company's tone was positive. Still, it is a $187M company with not much in sales. It may need new capital within the next 12 months as well.